Spironolactone inhibits podocyte motility via decreasing integrin β1 and increasing integrin β3 in podocytes under high-glucose conditions
Li Zhuo(China-Japan Friendship Hospital), Jianchao Ma(First Affiliated Hospital of GuangXi Medical University)
Cited by 15